Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 15/20 | 0.76 |
| ▸ | AVPR1A | P37288 | 5/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | HTR1A | P08908 | 1/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.66 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.66 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | HRH1 | P35367 | 1/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.66 |
| ▸ | GLP1R | P43220 | 1/20 | 0.66 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.66 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27164754 | 0.99 | AVPR2 (0.77) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658559 | 0.97 | AVPR2 (0.78) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL27164756 | 0.95 | AVPR2 (0.75) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658484 | 0.88 | AVPR2 (0.94) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658360 | 0.88 | AVPR2 (0.94) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658361 | 0.88 | AVPR2 (0.94) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL27164745 | 0.87 | AVPR2 (0.96) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658357 | 0.87 | AVPR2 (0.96) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL24658359 | 0.87 | AVPR2 (0.96) | AVPR2AVPR1AABCB11ADRB2HTR1A | |
| SCHEMBL27164731 | 0.86 | AVPR2 (1.00) | AVPR2AVPR1AABCB11ADRB2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240076279-A1 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | XUZHOU MEDICAL UNIVERSITY (CN) | 2024-03-07 | — | — | US | claimed |
| US-20240076279-A1 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | XUZHOU MEDICAL UNIVERSITY (CN) | 2024-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240076279-A1 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | AVPR1B, AVPR2, AVPR1A | AVPR2 2/4885AVPR1A 3/4885ABCB11 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.